期刊
NATURE MEDICINE
卷 13, 期 10, 页码 1253-1258出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nm1631
关键词
-
资金
- Medical Research Council [G9900989, G0300456] Funding Source: Medline
- Wellcome Trust [076994, 088291] Funding Source: Medline
- MRC [G9900989, G0300456] Funding Source: UKRI
- Medical Research Council [G0300456, G9900989] Funding Source: researchfish
Multiple sclerosis is a disease of the central nervous system that is associated with leukocyte recruitment and subsequent inflammation, demyelination and axonal loss. Endothelial vascular cell adhesion molecule- 1 ( VCAM- 1) and its ligand, alpha(4)beta(1) integrin, are key mediators of leukocyte recruitment, and selective inhibitors that bind to the alpha(4) subunit of alpha(4)beta(1) substantially reduce clinical relapse in multiple sclerosis. Urgently needed is a molecular imaging technique to accelerate diagnosis, to quantify disease activity and to guide specific therapy. Here we report in vivo detection of VCAM- 1 in acute brain inflammation, by magnetic resonance imaging in a mouse model, at a time when pathology is otherwise undetectable. Antibody- conjugated microparticles carrying a large amount of iron oxide provide potent, quantifiable contrast effects that delineate the architecture of activated cerebral blood vessels. Their rapid clearance from blood results in minimal background contrast. This technology is adaptable to monitor the expression of endovascular molecules in vivo in various pathologies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据